The investment seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in companies included in the IBD? 50 Index. The fund will generally hold all of the companies included in the IBD? 50 Index other than during periods when the fund is rebalanced due to changes in the constitution of the IBD? 50 Index. The fund, however, will not invest in the IBD? 50 Index companies in the same proportion as reflected in the index.
Inception Date: 08/04/2015
Primary Benchmark: IBD 50 Index USD
Primary Index: S&P 500 TR USD
Gross Expense Ratio: 1.13%
Management Expense Ratio: 0.80 %
|BABA||Alibaba Group Holding Limited American Depositary Shares each representing one||3.76 %|
|NVDA||NVIDIA Corporation||3.75 %|
|ANET||Arista Networks Inc.||3.63 %|
|IPGP||IPG Photonics Corporation||3.54 %|
|FIVE||Five Below Inc.||3.50 %|
|ALGN||Align Technology Inc.||3.46 %|
|YY||YY Inc.||3.44 %|
|HTHT||China Lodging Group Limited||3.43 %|
|OLED||Universal Display Corporation||3.21 %|
|TEAM||Atlassian Corporation Plc||3.15 %|
|IWP||iShares Russell Midcap Growth||0.25 %||
|IJK||iShares S&P Mid-Cap 400 Growth||0.25 %||
|VOT||Vanguard Mid-Cap Growth||0.07 %||
|MDYG||SPDR S&P 400 Mid Cap Growth ET..||0.15 %||
|IVOG||Vanguard S&P Mid-Cap 400 Growt..||0.20 %||
|RFG||Guggenheim S&P Midcap 400 Pure..||0.35 %||
|JKH||iShares Morningstar Mid-Cap Gr..||0.30 %||
|BFOR||Barron's 400||0.65 %||
|RYJ||Guggenheim Raymond James SB-1 ..||0.75 %||
|GDL||GDL Fund The of Beneficial Int..||0.00 %||
|Market Performance vs.
Industry/Classification (Mid-Cap Growth)
|Market Performance vs. Exchange (NYSE Arca)|
|Value||Sector Median||Percentile Rank||Grade||Market Median||Percentile Rank||Grade|
|Trailing 12 Months|
|Trailing 5 Years|
|Average Annual (5 Year Horizon)|
|Risk Return Profile|
|Volatility (Standard Deviation)||18.17%||7%||F||41%||F|
|Risk Adjusted Return||61.02%||13%||F||54%||F|
|Target Price Action||Rating Action||Analyst||Rating||Price||Date|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
The company has under performed its peers on annual average total returns in the past 5 years.